he efficacy of alogliptin to gastrin and glycemic control in patients with type 2 diabetes under treatment with gastric secretion inhibitor and gastroprotective agents
Not Applicable
- Conditions
- Patients with type 2 diabetes
- Registration Number
- JPRN-UMIN000011277
- Lead Sponsor
- ational Hospital Organization National Kochi Hospital,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
diabetic ketosis severe infection before and after operation patients with severe trauma past history of allergy against alogliptin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes and %changes in gastrin and HbA1c after 6 months from baseline
- Secondary Outcome Measures
Name Time Method Changes and %changes in the following parameters during the observation period Body weight Office blood pressure Serum creatinine HDL TG LD